Transl Clin Pharmacol.  2019 Dec;27(4):115-118. 10.12793/tcp.2019.27.4.115.

Korean clinical trials: its current status, future prospects, and enabling environment

• Chee DH

• KMID: 2467963
• DOI: http://doi.org/10.12793/tcp.2019.27.4.115

Abstract

No abstract available.

Figure

• 

  Figure 1 The global trend of industry-sponsored clinical trials (2014–2019E).[2]

• 

  Figure 2 The trend in the global share of clinical trials in the top-ranked countries conducting clinical trials, 2014–2018.[2]

Reference

1. Accessed 1 November 2019. https://www.koreaclinicaltrials.org/kr/contents/datainfo_data_01_tab02/view.do.

2. KoNECT annual analysis of ClinicalTrials.gov database. Internal data. 2019. 08.

3. Accessed 1 November 2019. http://www.korea.kr/news/pressReleaseView.do?newsId=155943465.

4. Accessed1 November 2019. https://www.mfds.go.kr/brd/m_99/view.do?seq=43284&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1.

5. KoNECT annual analysis of MFDS clinical trial authorization data, Internal data.

6. KoNECT survey on clinical trial activities of companies operating in Korea. Internal data. 2018.

7. Clinical Trials Statistics. KoNECT;2018. p. 22–23.

8. Contract research organizations global market opportunities and strategies to 2021, the business research company. 2018. 07. p. 30–31.